RELMADA THERAPEUTICS, INC. Operating Expenses
RELMADA THERAPEUTICS, INC. (RLMD) reported Operating Expenses of $15.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- RELMADA THERAPEUTICS, INC. operating expenses for the quarter ending 2026-06-30 was $15.01M, a 46.86% increase year-over-year.
- RELMADA THERAPEUTICS, INC. operating expenses for the quarter ending 2026-03-31 was $19.46M, a 6.82% increase year-over-year.
- RELMADA THERAPEUTICS, INC. operating expenses for the quarter ending 2025-12-31 was $20.33M, a 6.59% increase year-over-year.
- RELMADA THERAPEUTICS, INC. operating expenses for the quarter ending 2025-09-30 was $10.33M, a 55.12% decline year-over-year.
- RELMADA THERAPEUTICS, INC. operating expenses for fiscal 2025 was $59.10M, a 29.55% decline from fiscal 2024.
- RELMADA THERAPEUTICS, INC. operating expenses for fiscal 2024 was $83.89M, a 19.10% decline from fiscal 2023.
- RELMADA THERAPEUTICS, INC. operating expenses for fiscal 2023 was $103.70M, a 35.69% decline from fiscal 2022.
- RELMADA THERAPEUTICS, INC. operating expenses for fiscal 2022 was $161.25M, a 28.28% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 21 month | Operating Expenses 24 month | Operating Expenses 27 month | Operating Expenses 30 month | Operating Expenses 33 month | Operating Expenses 115 month | Operating Expenses 118 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.01M 10-Q · filed 2026-08-06 | $34.47M 10-Q · filed 2026-08-06 | $54.81M derived: sum of 3 quarters · filed 2026-08-06 | $65.13M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2026-03-31 | $19.46M 10-Q · filed 2026-05-12 | $39.79M derived: sum of 2 quarters · filed 2026-05-12 | $50.12M derived: sum of 3 quarters · filed 2026-05-12 | $60.34M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2025-12-31 | $20.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $30.66M derived: sum of 2 quarters · filed 2026-03-19 | $40.88M derived: sum of 3 quarters · filed 2026-08-06 | $59.10M 10-K · filed 2026-03-19 | |||||||||||
| 2025-09-30 | $10.33M 10-Q · filed 2025-11-13 | $20.55M derived: sum of 2 quarters · filed 2026-08-06 | $38.77M 10-Q · filed 2025-11-13 | $57.84M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2025-06-30 | $10.22M 10-Q · filed 2026-08-06 | $28.44M 10-Q · filed 2026-08-06 | $47.52M derived: sum of 3 quarters · filed 2026-08-06 | $70.52M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||
| 2025-03-31 | $18.22M 10-Q · filed 2026-05-12 | $37.29M derived: sum of 2 quarters · filed 2026-05-12 | $60.30M derived: sum of 3 quarters · filed 2026-05-12 | $79.12M derived: sum of 4 quarters · filed 2026-05-12 | |||||||||||
| 2024-12-31 | $19.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $42.08M derived: sum of 2 quarters · filed 2026-03-19 | $60.90M derived: sum of 3 quarters · filed 2026-03-19 | $83.89M 10-K · filed 2026-03-19 | |||||||||||
| 2024-09-30 | $23.01M 10-Q · filed 2025-11-13 | $41.83M derived: sum of 2 quarters · filed 2025-11-13 | $64.82M 10-Q · filed 2025-11-13 | $91.64M derived: sum of 4 quarters · filed 2025-11-13 | |||||||||||
| 2024-06-30 | $18.82M 10-Q · filed 2025-08-07 | $41.81M 10-Q · filed 2025-08-07 | $68.64M derived: sum of 3 quarters · filed 2025-08-07 | $91.33M derived: sum of 4 quarters · filed 2025-08-07 | |||||||||||
| 2024-03-31 | $22.99M 10-Q · filed 2025-05-12 | $49.82M derived: sum of 2 quarters · filed 2025-05-12 | $72.51M derived: sum of 3 quarters · filed 2025-05-12 | $98.54M derived: sum of 4 quarters · filed 2025-05-12 | |||||||||||
| 2023-12-31 | $26.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $49.52M derived: sum of 2 quarters · filed 2025-03-27 | $75.55M derived: sum of 3 quarters · filed 2025-03-27 | $103.70M 10-K · filed 2025-03-27 | |||||||||||
| 2023-09-30 | $22.69M 10-Q · filed 2024-11-07 | $48.72M derived: sum of 2 quarters · filed 2024-11-07 | $76.87M 10-Q · filed 2024-11-07 | $115.58M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||||
| 2023-06-30 | $26.03M 10-Q · filed 2024-08-07 | $54.18M 10-Q · filed 2024-08-07 | $92.88M derived: sum of 3 quarters · filed 2024-08-07 | $131.62M derived: sum of 4 quarters · filed 2024-08-07 | |||||||||||
| 2023-03-31 | $28.15M 10-Q · filed 2024-05-08 | $66.86M derived: sum of 2 quarters · filed 2024-05-08 | $105.59M derived: sum of 3 quarters · filed 2024-05-08 | $151.11M derived: sum of 4 quarters · filed 2024-05-08 | |||||||||||
| 2022-12-31 | $38.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $77.44M derived: sum of 2 quarters · filed 2024-03-19 | $122.95M derived: sum of 3 quarters · filed 2024-03-19 | $161.25M 10-K · filed 2024-03-19 | |||||||||||
| 2022-09-30 | $38.74M 10-Q · filed 2023-11-08 | $84.25M derived: sum of 2 quarters · filed 2023-11-08 | $122.55M 10-Q · filed 2023-11-08 | $156.73M derived: sum of 4 quarters · filed 2023-11-08 | |||||||||||
| 2022-06-30 | $45.51M 10-Q · filed 2023-08-08 | $83.81M 10-Q · filed 2023-08-08 | $117.99M derived: sum of 3 quarters · filed 2023-08-08 | $160.65M derived: sum of 4 quarters · filed 2023-08-08 | |||||||||||
| 2022-03-31 | $38.30M 10-Q · filed 2022-05-05 | $72.48M derived: sum of 2 quarters · filed 2023-03-23 | $115.13M derived: sum of 3 quarters · filed 2023-03-23 | $141.60M derived: sum of 4 quarters · filed 2023-03-23 | |||||||||||
| 2021-12-31 | $34.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $76.84M derived: sum of 2 quarters · filed 2023-03-23 | $103.30M derived: sum of 3 quarters · filed 2023-03-23 | $125.70M 10-K · filed 2023-03-23 | |||||||||||
| 2021-09-30 | $42.65M 10-Q · filed 2022-11-10 | $69.12M derived: sum of 2 quarters · filed 2022-11-10 | $91.52M 10-Q · filed 2022-11-10 | $112.44M derived: sum of 4 quarters · filed 2022-11-10 | |||||||||||
| 2021-06-30 | $26.46M 10-Q · filed 2022-08-11 | $48.87M 10-Q · filed 2022-08-11 | $69.79M derived: sum of 3 quarters · filed 2022-08-11 | $86.97M derived: sum of 4 quarters · filed 2022-08-11 | |||||||||||
| 2021-03-31 | $22.41M 10-Q · filed 2022-05-05 | $43.33M derived: sum of 2 quarters · filed 2022-05-05 | $60.51M derived: sum of 3 quarters · filed 2022-05-05 | $73.27M derived: sum of 4 quarters · filed 2022-05-05 | |||||||||||
| 2020-12-31 | $20.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $38.11M derived: sum of 2 quarters · filed 2022-03-25 | $50.86M derived: sum of 3 quarters · filed 2022-03-25 | $60.84M 10-K · filed 2022-03-25 | |||||||||||
| 2020-09-30 | $17.18M 10-Q · filed 2021-11-12 | $29.94M derived: sum of 2 quarters · filed 2021-11-12 | $39.92M 10-Q · filed 2021-11-12 | $44.48M derived: sum of 4 quarters · filed 2021-11-12 | |||||||||||
| 2020-06-30 | $12.76M 10-Q · filed 2021-08-10 | $22.73M 10-Q · filed 2021-08-10 | $27.30M derived: sum of 3 quarters · filed 2021-08-10 | $31.00M derived: sum of 4 quarters · filed 2021-08-10 | |||||||||||
| 2020-03-31 | $9.97M 10-Q · filed 2021-05-12 | $14.54M derived: sum of 2 quarters · filed 2021-05-12 | $18.25M derived: sum of 3 quarters · filed 2021-05-12 | $22.38M derived: sum of 4 quarters · filed 2021-05-12 | |||||||||||
| 2019-12-31 | $4.56M derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-24 | $8.27M 10-K · filed 2021-03-24 | $12.41M derived: sum of 3 quarters · filed 2021-03-24 | $15.11M 10-K · filed 2021-03-24 | |||||||||||
| 2019-09-30 | $3.71M 10-Q · filed 2020-11-12 | $7.84M derived: sum of 2 quarters · filed 2020-11-12 | $10.55M 10-Q · filed 2020-11-12 | $14.02M derived: sum of 4 quarters · filed 2020-11-12 | |||||||||||
| 2019-06-30 | $4.14M 10-Q · filed 2020-08-12 | $6.84M 10-Q · filed 2020-08-12 | $10.32M derived: sum of 3 quarters · filed 2020-08-12 | $12.73M 10-K · filed 2021-03-24 | |||||||||||
| 2019-03-31 | $2.70M 10-Q · filed 2020-05-15 | $6.18M derived: sum of 2 quarters · filed 2020-05-15 | $8.59M 10-Q · filed 2019-05-15 | $10.52M derived: sum of 4 quarters · filed 2020-05-15 | |||||||||||
| 2018-12-31 | $3.48M 10-Q · filed 2019-02-13 | $5.89M 10-KT · filed 2020-03-26 | $7.82M derived: sum of 3 quarters · filed 2020-03-26 | $10.37M derived: sum of 4 quarters · filed 2020-03-26 | |||||||||||
| 2018-09-30 | $2.41M 10-Q · filed 2019-11-13 | $4.34M derived: sum of 2 quarters · filed 2020-03-26 | $6.89M derived: sum of 3 quarters · filed 2020-03-26 | $8.35M derived: sum of 4 quarters · filed 2020-03-26 | |||||||||||
| 2018-06-30 | $1.93M derived: 10-KT 12 month − 10-Q 9 month · filed 2020-03-26 | $4.48M derived: sum of 2 quarters · filed 2020-03-26 | $5.94M derived: sum of 3 quarters · filed 2020-03-26 | $6.92M 10-KT · filed 2020-03-26 | |||||||||||
| 2018-03-31 | $2.55M 10-Q · filed 2019-05-15 | $4.01M derived: sum of 2 quarters · filed 2019-05-15 | $4.99M 10-Q · filed 2019-05-15 | $6.77M derived: sum of 4 quarters · filed 2019-05-15 | |||||||||||
| 2017-12-31 | $1.46M 10-Q · filed 2019-02-13 | $2.44M 10-Q · filed 2019-02-13 | $4.22M derived: sum of 3 quarters · filed 2019-02-13 | $6.50M derived: sum of 4 quarters · filed 2019-02-13 | |||||||||||
| 2017-09-30 | $980.86K 10-Q · filed 2018-11-13 | $2.76M derived: sum of 2 quarters · filed 2018-11-13 | $5.05M derived: sum of 3 quarters · filed 2018-11-13 | $6.58M derived: sum of 4 quarters · filed 2018-11-13 | |||||||||||
| 2017-06-30 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-28 | $4.07M derived: sum of 2 quarters · filed 2018-09-28 | $5.60M derived: sum of 3 quarters · filed 2018-09-28 | $7.22M 10-K · filed 2018-09-28 | |||||||||||
| 2017-03-31 | $2.28M 10-Q · filed 2018-05-14 | $3.82M derived: sum of 2 quarters · filed 2018-05-14 | $5.44M 10-Q · filed 2018-05-14 | $8.54M derived: sum of 4 quarters · filed 2018-05-14 | |||||||||||
| 2016-12-31 | $1.54M 10-Q · filed 2018-02-12 | $3.15M 10-Q · filed 2018-02-12 | $6.26M derived: sum of 3 quarters · filed 2018-02-12 | $9.00M derived: sum of 4 quarters · filed 2018-02-12 | |||||||||||
| 2016-09-30 | $1.62M 10-Q · filed 2017-11-14 | $4.72M derived: sum of 2 quarters · filed 2017-11-14 | $7.47M derived: sum of 3 quarters · filed 2017-11-14 | $13.19M derived: sum of 4 quarters · filed 2017-11-14 | |||||||||||
| 2016-06-30 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $5.85M derived: sum of 2 quarters · filed 2017-09-28 | $11.57M derived: sum of 3 quarters · filed 2017-09-28 | $16.22M 10-K · filed 2017-09-28 | |||||||||||
| 2016-03-31 | $2.75M 10-Q · filed 2017-05-15 | $8.47M derived: sum of 2 quarters · filed 2017-05-15 | $13.11M 10-Q · filed 2017-05-15 | $17.50M derived: sum of 4 quarters · filed 2017-05-15 | |||||||||||
| 2015-12-31 | $5.72M 10-Q · filed 2017-02-10 | $10.35M 10-Q · filed 2017-02-10 | $14.75M derived: sum of 3 quarters · filed 2017-02-10 | $19.33M derived: sum of 4 quarters · filed 2017-02-10 | |||||||||||
| 2015-09-30 | $4.63M 10-Q · filed 2016-11-10 | $9.03M derived: sum of 2 quarters · filed 2016-11-10 | $13.61M derived: sum of 3 quarters · filed 2016-11-10 | $18.00M derived: sum of 4 quarters · filed 2016-11-10 | |||||||||||
| 2015-06-30 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09 | $8.98M derived: sum of 2 quarters · filed 2016-09-09 | $13.37M derived: sum of 3 quarters · filed 2016-09-09 | $17.10M 10-K · filed 2016-09-09 | |||||||||||
| 2015-03-31 | $4.58M 10-Q · filed 2016-05-09 | -$4.57M 10-Q · filed 2015-05-15 | $8.96M derived: sum of 2 quarters · filed 2016-05-09 | $12.70M 10-Q · filed 2016-05-09 | -$12.68M 10-Q · filed 2015-05-15 | $26.34M derived: sum of 4 quarters · filed 2016-05-09 | |||||||||
| 2014-12-31 | $4.38M 10-Q · filed 2016-02-05 | -$4.38M 10-Q · filed 2015-02-13 | $8.11M 10-Q · filed 2016-02-05 | -$8.11M 10-Q · filed 2015-02-13 | $21.77M derived: sum of 3 quarters · filed 2016-02-05 | $21.05M derived: sum of 4 quarters · filed 2016-02-05 | |||||||||
| 2014-09-30 | $3.72M 10-Q · filed 2015-11-06 | -$3.72M 10-Q · filed 2014-11-07 | $17.38M derived: sum of 2 quarters · filed 2015-11-06 | $16.67M derived: sum of 3 quarters · filed 2015-11-06 | |||||||||||
| 2014-06-30 | $13.66M derived: 10-K 6 month − 10-Q 3 month · filed 2015-09-11 | $12.95M 10-K · filed 2015-09-11 | -$12.95M 10-KT · filed 2014-09-09 | ||||||||||||
| 2014-03-31 | -$711.90K 10-Q · filed 2015-05-15 | -$6.25M 10-Q · filed 2015-05-15 | -$18.61M 8-K · filed 2014-05-27 | ||||||||||||
| 2014-02-28 | $3.12K 10-Q · filed 2014-04-15 | $17.66K 10-Q · filed 2014-04-15 | $78.05K 10-Q · filed 2014-04-15 | ||||||||||||
| 2013-12-31 | -$5.06M 10-Q · filed 2015-02-13 | -$5.54M 10-Q · filed 2015-02-13 | $6.77M 10-K · filed 2015-09-11 | -$6.77M 8-K · filed 2014-05-27 | -$17.90M 8-K · filed 2014-05-27 | ||||||||||
| 2013-11-30 | $14.54K 10-Q · filed 2014-01-13 | $74.93K 10-Q · filed 2014-01-13 | |||||||||||||
| 2013-09-30 | -$481.84K 10-Q · filed 2014-11-07 | ||||||||||||||
| 2013-08-31 | $12.36K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-16 | $32.16K derived: sum of 2 quarters · filed 2013-12-16 | $46.11K 10-K · filed 2013-12-16 | $60.39K 10-K · filed 2013-12-16 | |||||||||||
| 2013-05-31 | $19.80K 10-Q · filed 2013-07-12 | $33.74K 10-Q · filed 2013-07-12 | $48.03K 10-Q · filed 2013-07-12 | ||||||||||||
| 2013-03-31 | -$600.92K 8-K · filed 2014-05-27 | ||||||||||||||
| 2013-02-28 | $4.63K 10-Q · filed 2014-04-15 | $13.95K 10-Q · filed 2014-04-15 | $23.09K derived: sum of 3 quarters · filed 2014-04-15 | $25.68K derived: sum of 4 quarters · filed 2014-04-15 | $28.23K 10-Q · filed 2013-05-03 | ||||||||||
| 2012-12-31 | -$3.16M 10-KT · filed 2014-09-09 | ||||||||||||||
| 2012-11-30 | $9.32K 10-Q · filed 2014-01-13 | $18.46K derived: sum of 2 quarters · filed 2014-01-13 | $21.05K derived: sum of 3 quarters · filed 2014-01-13 | $23.07K derived: sum of 4 quarters · filed 2014-01-13 | |||||||||||
| 2012-08-31 | $9.15K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-16 | $11.73K derived: sum of 2 quarters · filed 2013-12-16 | $13.76K derived: sum of 3 quarters · filed 2013-12-16 | $14.19K 10-K · filed 2013-12-16 | |||||||||||
| 2012-05-31 | $2.59K 10-Q · filed 2013-07-12 | $4.61K derived: sum of 2 quarters · filed 2013-07-12 | $5.05K 10-Q · filed 2013-07-12 | ||||||||||||
| 2012-02-29 | $2.02K 10-Q · filed 2013-05-03 | $2.46K 10-Q · filed 2013-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |